Get in Touch With the Apterna Team

We welcome conversations with investors, scientific collaborators, and partners who share our mission to redefine the future of RNA therapeutics. Whether you’re exploring research collaboration, media engagement, or investment opportunities, we’d be pleased to hear from you.

Your Connection to Apterna

Apterna is a preclinical-stage biotechnology company headquartered in the United Kingdom with partnerships across Europe and North America. Our focus on transparency and collaboration means that communication is central to our culture.

Use the contact channels below to reach the appropriate team — we aim to respond to all enquiries within 2–3 working days.

How Can We Help You?

Apterna Contact Table
Department / Purpose Email Address Description
General Enquiries info@apterna.com For general questions about Apterna, our mission, or our programmes.
Investor Relations investors@apterna.com For funding, due diligence, and corporate partnership discussions.
Scientific & Research Collaborations research@apterna.com For academic partnerships, preclinical collaboration, and platform licensing.
Media & Communications press@apterna.com For interviews, media requests, and public statements.
Career Opportunities careers@apterna.com For job applications, internships, and HR-related enquiries.
Note: If you are unsure which address to use, please contact info@apterna.com, and your message will be routed to the appropriate department.

Send Us a Message

For convenience, you may also use the secure form below. Please provide enough detail for our team to direct your enquiry efficiently.

 

Corporate Headquarters

Apterna Ltd
c/o Innovation Centre
Imperial Scale Space
58 Wood Lane,
W12 7RZ
London
United Kingdom

Collaboration Is at the Heart of Our Mission

Apterna’s technologies are designed to enable progress across the RNA ecosystem. We actively engage with pharmaceutical, academic, and investor partners who share our goal of developing precision RNA medicines for patients in need.

Follow Our Progress

Keep up to date with Apterna’s latest developments, news, and publications by following us on our official channels:

Newsletter Signup

Receive quarterly updates and announcements straight to your inbox.

Data Protection and Confidentiality

Apterna Ltd complies with all applicable data-protection laws, including the UK GDPR. Information submitted through this website is used solely for the purpose of responding to enquiries and will not be shared with third parties without consent. For further details, please review our Privacy Policy.

We Look Forward to Hearing From You

At Apterna, every partnership begins with a conversation. Whether you are an investor, researcher, or simply someone interested in the potential of RNA therapeutics, we welcome your engagement and curiosity.
Scroll to Top